Skip to main content
Log in

Ergebnisse der SIGNIFY-Studie

Anstieg des Herzinfarkt- und Sterberisikos durch Ivabradin bei Patienten mit stabiler Angina pectoris

Results of the SIGNIFY study

Increase in risk of cardiac infarction and death by ivabradine in patients with stable angina pectoris

  • Journal Club
  • Published:
Der Kardiologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Colin P, Ghaleh B, Monnet X et al (2003) Contributions of heart rate and contractility to myocardial oxygen balance during exercise. Am J Physiol Heart Circ Physiol 284:H676–H682

    CAS  PubMed  Google Scholar 

  2. Fox K, Ford I, Steg PG et al (2014) Ivabradine in stable coronary artery disease without clinical heart failure. N Engl J Med 371:1091–1099

    Article  CAS  PubMed  Google Scholar 

  3. Fox K, Ford I, Steg PG et al (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372:807–816

    Article  CAS  PubMed  Google Scholar 

Download references

Interessenkonflikt

C. Özcelik gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Özcelik.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Özcelik, C. Ergebnisse der SIGNIFY-Studie. Kardiologe 8, 446–447 (2014). https://doi.org/10.1007/s12181-014-0630-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12181-014-0630-8

Navigation